Rhythm Pharmaceuticals share price today
(NASDAQ: RYTM)

Name: Rhythm Pharmaceuticals Share Price Today (NASDAQ: RYTM) - Rhythm Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Rhythm Pharmaceuticals share price is $58.47 & ₹5,057.07 as on 24 Jan 2025, 2.30 'hrs' IST

$58.47

▲

1.24

(2.17%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Rhythm Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Rhythm Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Rhythm Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Rhythm Pharmaceuticals share price movements

Today's Low: $56.04
Today's High: $58.61
$58.47
4.16%
Downside
Day's Volatility :4.39%
Upside
0.24%
52 Weeks Low: $35.17
52 Weeks High: $68.58
$58.47
39.85%
Downside
52 Weeks Volatility :48.72%
Upside
14.74%

Rhythm Pharmaceuticals Returns

Period	Rhythm Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	17.88%	-5.5%	0.0%
6 Months	16.68%	-4.3%	0.0%
1 Year	29.54%	1.6%	0.0%
3 Years	641.32%	9.8%	-11.0%

Rhythm Pharmaceuticals Key Statistics

in dollars & INR

Previous Close	$57.23
Open	$56.54
Today's High	$58.61
Today's Low	$56.035
Market Capitalization	$3.5B
Today's Volume	$337.4K
52 Week High	$68.58
52 Week Low	$35.17
Revenue TTM	$112.5M
EBITDA	$-263.9M
Earnings Per Share (EPS)	$-4.32
Profit Margin	-230.11%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-147.9%

How to invest in Rhythm Pharmaceuticals Stock (RYTM) from India?

It is very easy for Indian residents to invest directly in Rhythm Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rhythm Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rhythm Pharmaceuticals or RYTM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rhythm Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rhythm Pharmaceuticals shares which would translate to 0.015 fractional shares of Rhythm Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rhythm Pharmaceuticals, in just a few clicks!

Returns in Rhythm Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

Rhythm Pharmaceuticals investment value today

Current value as on today

₹1,36,399

Returns

₹36,399

(+36.4%)

Returns from Rhythm Pharmaceuticals Stock

₹32,345 (+32.34%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Rhythm Pharmaceuticals

-63%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Rhythm Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Jan 24, 2025. -63% less investors are searching Rhythm Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Rhythm Pharmaceuticals

PRIMECAP Management Company
11.74%
BlackRock Inc
11.21%
Baker Bros Advisors LP
10.41%
RA Capital Management, LLC
9.90%
Goldman Sachs Group Inc
6.31%
Perceptive Advisors LLC
5.79%

Analyst Recommendation on Rhythm Pharmaceuticals

Buy

93%Buy

6%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Rhythm Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Rhythm Pharmaceuticals

What analysts predicted

Upside of 25.16%

Target:

$73.18

Current:

$58.47

Insights on Rhythm Pharmaceuticals

Price Movement
In the last 3 years, RYTM stock has moved up by 684.0%
Increasing Revenue
Revenue is up for the last 9 quarters, 4.28M → 33.25M (in $), with an average increase of 20.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -32.26M → -44.97M (in $), with an average decrease of 39.4% per quarter
RYTM vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 40.5% return, outperforming this stock by 4.4%
Price to Sales
ForRYTM every $1 of sales, investors are willing to pay $30.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.1 for every $1 of sales.

Rhythm Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Rhythm Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Rhythm Pharmaceuticals Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Rhythm Pharmaceuticals Inc	1.22%	16.68%	29.54%	641.32%	193.04%
Biontech Se	0.91%	34.01%	18.85%	-26.4%	246.9%
Regeneron Pharmaceuticals, Inc.	-4.82%	-36.95%	-28.33%	12.74%	100.35%
Vertex Pharmaceuticals Incorporated	4.86%	-13.58%	-0.46%	88.45%	88.24%
Alnylam Pharmaceuticals, Inc.	9.57%	13.5%	44.91%	103.56%	127.75%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Rhythm Pharmaceuticals Inc	NA	NA	NA	-4.07	-1.48	-0.46	NA	0.18
Biontech Se	160.8	NA	0.04	-3.33	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	17.02	17.02	1.05	44.99	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.1	0.48	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Rhythm Pharmaceuticals Inc	Buy	$3.5B	193.04%	NA	-230.11%
Biontech Se	Buy	$28.1B	246.9%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$75.6B	100.35%	17.02	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$110.2B	88.24%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$34.2B	127.75%	NA	-15.86%

Rhythm Pharmaceuticals Dividend announcements

Rhythm Pharmaceuticals Earnings
Rhythm Pharmaceuticals’s price-to-earnings ratio stands at None
Read More

About Rhythm Pharmaceuticals

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Organization	Rhythm Pharmaceuticals
Employees	226
CEO	Dr. David P. Meeker M.D.
Industry	Health Technology

Management People of Rhythm Pharmaceuticals

Name	Title
Dr. David P. Meeker M.D.	Chairman, President & CEO
Mr. Hunter C. Smith M.B.A.	CFO & Treasurer
Mr. Joseph Shulman	Chief Technical Officer
Mr. Yann Mazabraud	Executive VP & Head of International
Ms. Jennifer Lee	Executive VP & Head of North America
Mr. Christopher German	Corporate Controller, Principal Accounting Officer & Executive Director
Dr. Alastair Garfield Ph.D.	Chief Scientific Officer
Mr. David Connolly	Head of Investor Relations & Corporate Communications
Mr. Jim Flaherty	Senior VP & General Counsel
Ms. Sarah Ryan	Vice President of Sales & Marketing

Important FAQs about investing in Rhythm Pharmaceuticals (RYTM) from India :

What is Rhythm Pharmaceuticals share price today?

Rhythm Pharmaceuticals share price today stands at $58.47, Open: $56.54 ; Previous Close: $57.23 ; High: $58.61 ; Low: $56.04 ; 52 Week High: $68.58 ; 52 Week Low: $35.17. The stock opens at $56.54, after a previous close of $57.23. The stock reached a daily high of $58.61 and a low of $56.04, with a 52-week high of $68.58 and a 52-week low of $35.17.

Can Indians buy Rhythm Pharmaceuticals shares?

Yes, Indians can invest in the Rhythm Pharmaceuticals (RYTM) from India.

With INDmoney, you can buy Rhythm Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Rhythm Pharmaceuticals at zero transaction cost.

How can I buy Rhythm Pharmaceuticals shares from India?

It is very easy to buy Rhythm Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rhythm Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Rhythm Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Rhythm Pharmaceuticals stocks?

To start investing in Rhythm Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.